These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 34740325)
1. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma. Yang C; Huang S; Cao F; Zheng Y BMC Cancer; 2021 Nov; 21(1):1182. PubMed ID: 34740325 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of an immune prognostic signature in colorectal cancer. Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948 [TBL] [Abstract][Full Text] [Related]
3. Development of a Novel Lipid Metabolism-related Gene Prognostic Signature for Patients with Colorectal Cancer. Zhan J; Cen W; Zhu J; Ye Y Recent Pat Anticancer Drug Discov; 2024; 19(2):209-222. PubMed ID: 37723964 [TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer. Li W; Jin X; Guo S; Xu F; Su X; Jiang X; Wang G Aging (Albany NY); 2021 Feb; 13(4):5506-5524. PubMed ID: 33536348 [TBL] [Abstract][Full Text] [Related]
6. Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature. Shen L; Huang H; Li J; Chen W; Yao Y; Hu J; Zhou J; Huang F; Ni C Front Immunol; 2023; 14():1199465. PubMed ID: 37469520 [TBL] [Abstract][Full Text] [Related]
7. A Pyroptosis-Related Gene Signature Predicts Prognosis and Tumor Immune Microenvironment in Colorectal Cancer. Li L; Li Y; Lin J; Pang W Technol Cancer Res Treat; 2024; 23():15330338241277584. PubMed ID: 39155627 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
9. Exploration of bacterial lipopolysaccharide-related genes signature based on T cells for predicting prognosis in colorectal cancer. Cao L; Ba Y; Chen F; Zhang S; Zhang H Aging (Albany NY); 2024 Aug; 16(15):11606-11625. PubMed ID: 39115879 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of an immune-related gene signature predictive of overall survival in colon cancer. Zhang X; Zhao H; Shi X; Jia X; Yang Y Aging (Albany NY); 2020 Dec; 12(24):26095-26120. PubMed ID: 33401247 [TBL] [Abstract][Full Text] [Related]
11. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer. Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer. Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968 [TBL] [Abstract][Full Text] [Related]
13. A five-immune-related genes-based prognostic signature for colorectal cancer. Zhu L; Wang H; Wang Z Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411 [TBL] [Abstract][Full Text] [Related]
14. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma. Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q Front Immunol; 2021; 12():693062. PubMed ID: 34497605 [TBL] [Abstract][Full Text] [Related]
15. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer. Zhang C; Zeng C; Xiong S; Zhao Z; Wu G Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720 [TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer. Zhang X; Shi X; Zhao H; Jia X; Yang Y Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients. Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005 [TBL] [Abstract][Full Text] [Related]
19. A New Genetic Signature of Lactate Metabolism-Associated Genes Predicting Clinically Distinctive Features and Tumor Microenvironment in Colorectal Cancer. Wang K; Lou Y; Tao Z Cancer Control; 2024; 31():10732748241272721. PubMed ID: 39121198 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy. Huang X; Sun Y; Song J; Huang Y; Shi H; Qian A; Cao Y; Zhou Y; Wang Q Front Immunol; 2023; 14():1301452. PubMed ID: 38045683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]